Mumbai, India , is rapidly emerging as a key hub for the manufacture of Lenacapavir Sodium API (CAS 2189684-53-3). Several companies have established substantial manufacturing facilities focusing on this critical antiviral compound. Identifying the absolute top manufacturers can be complex due to